Unknown PHASE2 INTERVENTIONAL 2-arm NCT03613584

Von Willebrand Factor Concentrate During ECMO Support

A Double-blind, Placebo-controlled Pilot Trial to Investigate the Administration of Von Willebrand Factor Concentrate (Willfact®, LFB France) in Adult Patients During Extracorporeal Membrane Oxygenation

Sponsor: LFB BIOMEDICAMENTS

Conditions Acquired Von Willebrand Disease

Interventions Saline Solution Von Willebrand Factor

Updated 7 times since 2018 Last updated: Mar 11, 2020 Started: Apr 16, 2018 Primary completion: Mar 10, 2021 Completion: Mar 10, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Acquired Von Willebrand Disease and is currently ongoing. LFB BIOMEDICAMENTS leads this study, which shows 7 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Apr 2022 — Jul 2024 [monthly]

Unknown Status PHASE2

Status: Active Not Recruiting → Unknown Status
Jan 2021 — Apr 2022 [monthly]

Active Not Recruiting PHASE2
Apr 2020 — Jan 2021 [monthly]

Active Not Recruiting PHASE2

Status: Recruiting → Active Not Recruiting

▶ Show 2 earlier versions

Sep 2019 — Apr 2020 [monthly]

Recruiting PHASE2
Sep 2018 — Sep 2019 [monthly]

Recruiting PHASE2

First recorded

Apr 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

LFB BIOMEDICAMENTS
Tirol Kiniken GmbH

Data source: Tirol Kiniken GmbH

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Innsbruck, Austria